Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Buccal Film for Chronic Non-Radicular Low Back Pain
NCT05419297Phase 4Unknown
- Sponsor
- Carolinas Pain Institute
- Start
- Aug 2022
- Primary completion
- Jul 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of buprenorphine in chronic low back pain (CLBP) (2 arms), sponsored by Carolinas Pain Institute. Primary endpoints: Numeric Rating Scale at 20 weeks, Patient Global Impression of Function at 20 weeks and 7 more. Status: unknown.
02
Drugs
buprenorphine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT05419297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05419297.